Ann: Options exercise, page-19

AGH is creeping up... currently 135M MC. Off its highs for sure but its on the way up, partially due to the TGA Ann hype and getting a license for their manufacturing plant in Canada.

With IHLOB conversions our cash balance should be above 10M. Similar to theirs.

Our oils sales already getting close to theirs, I would like to see the Q3 Quarterly continue to have that insane growth rate.
If we get 1M sales this quarter, AGH got 1.5M last quarter.

Wouldnt take much to assume 10c+ from oils alone should be a decent peer valuation as we'd be around 2/3 their MC.

And again... once our IP comes into play with FDA EUA possibility for IHL-675A and of course the Phase 2B Human Trial for OSA IHL-42X, that one will be ridiculous. Will add 9 figures to the market cap if successful, like most other Phase 2B Human Trials usually do.